Melatonin supplements and cancer: what the evidence actually shows

Melatonin is a hormone your own brain makes when it gets dark. Its job is timing. It helps set your circadian rhythm, the roughly 24-hour internal clock that decides when you feel sleepy. It also helps with sleep itself.

Because your body already makes it, melatonin has a reputation as gentle and natural. Online, that reputation gets stretched too far, all the way to claims that melatonin fights tumors. The federal review of melatonin does not back that claim up.

The National Center for Complementary and Integrative Health, part of NIH, sums up where the science stands. On cancer specifically, its answer is short and careful: studies of melatonin supplements for cancer symptoms or treatment side effects have been small, and the results have been mixed.

Read that slowly, because both halves matter.

• Small means the studies did not include enough people to settle the question.
• Mixed results means different studies pointed different ways.

That combination is what "we do not know" looks like in research language. It is not a hidden yes.

The review is blunt about one more thing: do not use unproven products in place of standard cancer treatment. That warning exists because delaying treatment that works is a harm in itself.

The same review points to areas where melatonin has been studied more usefully. It names melatonin as possibly helpful for jet lag, for delayed sleep-wake phase disorder, for some sleep disorders in children, and for anxiety before and after surgery. For jet lag, NCCIH reports that studies found melatonin may be better than a placebo — an inactive substance — at reducing symptoms after both eastward and westward flights.

For long-term insomnia, the picture is weaker. Two groups, the American Academy of Sleep Medicine and the American College of Physicians, found there is not enough strong evidence to say whether melatonin works, or whether it is safe, for chronic insomnia.

None of that is a cancer claim. Sleep help and cancer treatment are two different questions with two different sets of evidence.

There is a practical issue worth knowing before you buy anything. Reviewers found that some melatonin supplements do not contain what the label says.

This matters more than it sounds. If the amount in the capsule does not match the printed amount, you cannot really know what dose you took. Neither can your care team. That is a good reason to bring the actual bottle to an appointment rather than describe it from memory.

Short-term use looks safe for most people, per the review. The long-term effects are less clear.

When you see a supplement called anti-cancer, a few questions cut through most of the noise:

• Were the studies done in people, or only in cells and animals?
• How many people took part?
• Did independent studies agree with each other?
• Is anyone telling you to use this instead of treatment?

For melatonin and cancer, the honest answers are: small studies, results that disagree, and no basis for replacing treatment.

That is an unsatisfying answer if you hoped for something simple to add to your routine. It is, though, the accurate one. Wanting to do something active for your own health is a fair instinct. The useful move is to route that instinct through your care team. They can tell you what is worth adding, and what might quietly interfere with the treatment you are already getting.

Supplement talks in clinic sometimes go badly, because both sides expect a fight. It helps to open with a question rather than a statement: "I have been thinking about trying this, is there any reason not to?"

That framing does two useful things. It gets the product onto your record, which matters if a side effect shows up later. And it invites your team to talk about interactions instead of lecturing you about evidence.

Keep in mind what reviewers found about labels. If the amount in the capsule may not match what is printed, the actual bottle tells your team more than your description of it ever could.

Finally, be wary of anywhere selling melatonin with cancer claims attached. The federal summary describes small studies with mixed results on cancer symptoms and treatment side effects. Anyone turning that into a confident promise has gone well past what that source actually shows.